Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study "ADTCR"


Phase N/A Results N/A

Summary of Purpose

The research focuses on the safety profile of androgen-deprivation therapy (ADT). The hypothesis is that safety issue, as regards to cardiovascular risk, is not homogenous across the spectrum of androgen-deprivation therapy modalities. Our study will encompass all ADT modalities including intermittent ADT. ADT is a cornerstone therapy in prostate cancer management. Decisions about ADT should weigh ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 April 2017.

1 Apr 2015 6 Sep 2016 1 Dec 2017 1 Dec 2017 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample